News provided by Ro May 22, 2025, 08:05 ET Patients can come to Ro for the lowest cost FDA-approved GLP-1s anywhere NEW YORK, May 22, 2025 /PRNewswire/ -- Ro today announced it is offering Novo Nordisk's first month discounted cash price of $199 for Wegovy for new patients
We believe in providing helpful information to our community, which is why we want patients to understand emerging options like the GLP-1 patch
Their tirzepatide pricing starts at $279 and rises to $399
Comment which Patch interest you the most and I will choose a winner tonight
To view a copy of this license, visit About this article Cite this article Astrup, A., Carraro, R., Finer, N
The adverse effects of GLP-1RA, such as nausea, constipation, and diarrhea, are thought to be the result of the pharmacological action of GLP-1, but the mechanisms have not been fully elucidated